SMS Pharmaceuticals Ltd. submitted a compliance certificate under Regulation 74(5) of SEBI for the quarter ending March 31, 2024, confirming proper dematerialization and handling of securities. The certificate was issued by Aarthi Consultants Private Limited, their Registrar and Share Transfer Agent.